William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 69,622 shares at $28.05 ($2.0M) on 2024-07-16, disclosed to the SEC on 2024-07-18.
Scheduled sale ($2.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.05 | 5,008 | $140K | 7.2% |
| 2 | $28.05 | 5,008 | $140K | 7.2% |
| 3 | $28.05 | 29,803 | $836K | 42.8% |
| 4 | $28.05 | 29,803 | $836K | 42.8% |
| Total | $28.05 avg | 69,622 | $2.0M | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |